Xia Yu, director at Summit Therapeutics, buys $9.9 million in shares
Jill L. Robinson, Executive Vice President, CFO, and Treasurer of Atlanta Braves Holdings, Inc. (NASDAQ:BATRK), a $2.75 billion market cap company, sold 40,000 shares of Series C Common Stock on August 15, 2025, for a total of $1.75 million. According to InvestingPro analysis, the stock is currently trading above its Fair Value, with the share price near its 52-week high of $47.18. The sales were executed at a weighted average price of $43.82, with individual prices ranging from $43.68 to $44.12.
According to a Form 4 filing with the Securities and Exchange Commission, the sales were conducted under a pre-arranged Rule 10b5-1 sales plan adopted on May 15, 2025. Following the transaction, Robinson directly owns 68,755 shares of Series C Common Stock.
On the same day, Robinson also exercised stock options to acquire 40,000 shares of Series C Common Stock at an exercise price of $27.18, for a total value of $1,087,200. These options stemmed from a right to buy, and after the transaction, Robinson directly owns 150,263 shares. For deeper insights into Atlanta Braves Holdings’ financial health and valuation metrics, including 8 additional ProTips and comprehensive analysis, visit InvestingPro.
In other recent news, Atlanta Braves Holdings reported its Q2 2025 earnings, showcasing a strong financial performance with revenues exceeding forecasts. The company achieved a revenue of $312 million, surpassing the anticipated $297.2 million, which represents a 5.13% surprise. Earnings per share were reported at $0.46. This recent development highlights the company’s ability to outperform revenue expectations. Despite the positive earnings report, other factors influenced the stock’s pre-market trading. Analyst reactions and future projections were not discussed in the available reports. These results indicate a noteworthy quarter for Atlanta Braves Holdings.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.
